Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipid IIIWTA is a critical lipid-linked intermediate in the biosynthesis of wall teichoic acids (WTA) in Gram-positive bacteria. It consists of an undecaprenyl carrier linked via a pyrophosphate (diphosphate) group to a sugar-polyol chain, typically comprising N-acetylglucosamine, N-acetylmannosamine, and glycerol-phosphate or ribitol-phosphate units (Pereira et al., 2008; Brown et al., 2013). The pyrophosphate moiety of Lipid IIIWTA serves as a highly conserved and essential target for a new class of antibiotics, including teixobactin and clovibactin (Ling et al., 2015; Shukla et al., 2023). These drugs bind tightly to the pyrophosphate group, effectively sequestering the precursor and halting the assembly of the bacterial cell wall (Weingarth et al., 2023). Because the pyrophosphate moiety is a fundamental structural component that does not vary between bacterial strains, drugs targeting this site are less prone to the development of resistance. Inhibition of Lipid IIIWTA synthesis leads to a deficiency in WTAs, which are vital for maintaining cell wall integrity, regulating autolytic enzymes, and facilitating host-pathogen interactions (Homma et al., 2016).
Binding to the conserved pyrophosphate moiety of lipid-linked cell wall precursors, leading to inhibition of wall teichoic acid and peptidoglycan synthesis, and subsequent cell lysis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipid IIIWTA pyrophosphate moiety (Lipid IIIWTA).